U.S. Markets closed

Nymox Pharmaceutical Corporation (NYMX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.52-0.08 (-2.22%)
At close: 4:00PM EDT

3.60 0.00 (0.00%)
After hours: 4:00PM EDT

People also watch
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue283.6112,761.2652,949.509
Cost of Revenue173.023160.315173.667
Gross Profit110.5882,600.952,775.842
Operating Expenses
Research Development6,797.7688,649.514,761.557
Selling General and Administrative6,182.21811,611.7442,738.99
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-12,869.398-17,660.304-4,724.705
Income from Continuing Operations
Total Other Income/Expenses Net--189.575
Earnings Before Interest and Taxes-12,869.398-17,660.304-4,535.13
Interest Expense240.21233.559110.963
Income Before Tax-13,109.608-17,893.863-4,646.093
Income Tax Expense---52
Minority Interest--400
Net Income From Continuing Ops-13,109.608-17,893.863-4,594.093
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-13,109.608-17,893.863-4,594.093
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-13,109.608-17,893.863-4,594.093